These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26793851)

  • 1. PREDISPOSANT FACTORS FOR INTIMAL HYPERPLASIA AND THEIR MECHANISMS OF ACTION IN OPEN VASCULAR SURGERY. A REVIEW.
    Pătruţ GV; Ionac M
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1066-76. PubMed ID: 26793851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The god of small things: the biology of intimal hyperplasia.
    Williams D
    Med Device Technol; 1999 Oct; 10(8):8-11. PubMed ID: 10724779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.
    Kloppenburg GT; Grauls GE; Bruggeman CA; Stassen FR
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):31-4. PubMed ID: 18854336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms in intimal hyperplasia.
    Newby AC; Zaltsman AB
    J Pathol; 2000 Feb; 190(3):300-9. PubMed ID: 10685064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury.
    Li JM; Singh MJ; Itani M; Vasiliu C; Hendricks G; Baker SP; Hale JE; Rohrer MJ; Cutler BS; Nelson PR
    J Vasc Surg; 2004 May; 39(5):1074-83. PubMed ID: 15111864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injury in vascular surgery--the intimal hyperplastic response.
    Zubilewicz T; Wronski J; Bourriez A; Terlecki P; Guinault AM; Muscatelli-Groux B; Michalak J; Méllière D; Becquemin JP; Allaire E
    Med Sci Monit; 2001; 7(2):316-24. PubMed ID: 11257743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eComment: Femorocrural bypass surgery and intimal hyperplasia.
    Hudorovic N
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):194. PubMed ID: 19628537
    [No Abstract]   [Full Text] [Related]  

  • 9. Can intimal hyperplasia and distal anastomotic intimal hyperplasia be controlled and prevented?
    Sottiurai VS
    Ann Vasc Surg; 2007 May; 21(3):289-91. PubMed ID: 17484962
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased vascular injury reduces the degree of intimal hyperplasia following angioplasty in rabbits.
    Fogelstrand P; Mellander S; Mattsson E
    J Vasc Res; 2011; 48(4):307-15. PubMed ID: 21273785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intimal hyperplasia in vascular grafts.
    Lemson MS; Tordoir JH; Daemen MJ; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):336-50. PubMed ID: 10801366
    [No Abstract]   [Full Text] [Related]  

  • 12. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics of vein graft intimal hyperplasia: 100 years on.
    Wallitt EJ; Jevon M; Hornick PI
    Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arteriovenous access failure: more than just intimal hyperplasia?
    Rothuizen TC; Wong C; Quax PH; van Zonneveld AJ; Rabelink TJ; Rotmans JI
    Nephrol Dial Transplant; 2013 May; 28(5):1085-92. PubMed ID: 23543595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intimal hyperplasia: slow but deadly.
    Mills B; Robb T; Larson DF
    Perfusion; 2012 Nov; 27(6):520-8. PubMed ID: 22751382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical model of venous neointimal hyperplasia formation.
    Budu-Grajdeanu P; Schugart RC; Friedman A; Valentine C; Agarwal AK; Rovin BH
    Theor Biol Med Model; 2008 Jan; 5():2. PubMed ID: 18215280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives].
    Ducasse E; Cosset JM; Eschwège F; Chevalier J; De Ravignan D; Puppinck P; Lartigau E
    J Mal Vasc; 2003 Jun; 28(3):130-44. PubMed ID: 12910189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of angioscopic vein graft preparation on development of neointimal hyperplasia in an organ culture model of human saphenous vein.
    Wilson YG; Davies AH; Southgate K; Currie IC; Knight D; Patton D; Baird RN; Lamont PM; Angelini GD
    J Endovasc Surg; 1996 Nov; 3(4):436-44. PubMed ID: 8959504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.